What Made Scientific does

Made Scientific is a cell therapy contract development and manufacturing organization (CDMO) founded in 2019 and headquartered in Princeton, New Jersey. The company provides end-to-end GMP manufacturing services for autologous and allogeneic cell therapies, spanning T cells, NK cells, HSCs, MSCs, iPSCs, TILs, and exosomes, and serves biotech companies, pharmaceutical firms, and academic institutions from pre-clinical development through commercial phases. Its service portfolio includes process and analytical development, GMP cell banking and drug product manufacture, aseptic fill and finish, QC lot release and stability studies, and regulatory consulting for IND and BLA submissions.

The company's technical platform is anchored by a 60,000 ft² Princeton facility equipped with 5 ISO 7/Grade B cleanrooms, BSL-2 compliance, and infrastructure meeting US FDA (21 CFR 1271, 21 CFR 210/211) and EU Annex 1 standards. Recent capability additions include the MadeFast™ single-step CAR-T manufacturing platform with RapidCell™, an iPSC manufacturing platform integrated with Pluristyx's GMP iPSC lines and derivative cell types (iNK, iMSC), and an AI-driven robotic automation platform developed through an exclusive partnership with Streamline Bio. A 12,000 ft² expansion adding 9,000 ft² of new GMP cleanroom space is underway, with full capacity projected to deliver approximately 5,000 additional manufacturing batches per year.

Made Scientific operates a B2B, consultative sales model with project-based contracts, dedicated capacity agreements, and per-batch manufacturing fees; pricing is quote-based and negotiated per project rather than tier-based or subscription. The company is privately held and backed by GC Corporation of South Korea as a long-term strategic shareholder, with two GC executives (Jin Pyun and Soyoung Park) holding board seats. GTM combines direct enterprise sales to cell therapy developers, technical content marketing through the website's insights section, LinkedIn presence, and participation in advanced therapy conferences such as ISSCR 2026 and Meeting on the Mesa. The Made Scientific Foundry™ workforce development program, with Core, Boost, and Scholar tracks, supports training on actual CDMO equipment and includes an academic collaboration with NJIT.

Name

Made Scientific

Legal name

Made Scientific, Inc.

Website

https://madescientific.com

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

11–50 employees

Short description

Made Scientific is a Princeton, NJ-based cell therapy CDMO founded in 2019, providing end-to-end GMP manufacturing, process development, and analytical services for autologous and allogeneic therapies. Backed by South Korea's GC Corporation, it serves biotech, pharma, and academic clients from preclinical through commercial phases.

Ownership category

akta.pro rank

Headquarters

HQ city

Princeton

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

1. Contract Development and Manufacturing Services: Full-service CDMO providing end-to-end cell therapy manufacturing services from pre-clinical through commercial phases. Revenue generated through project-based contracts, dedicated capacity agreements, and per-batch manufacturing fees. Services include process development, GMP manufacturing, quality control, regulatory consulting, and fill-finish services.

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Made Scientific is a cell therapy Contract Development and Manufacturing Organization (CDMO) providing end-to-end GMP manufacturing services for autologous and allogeneic cell therapies including T cells, NK cells, HSCs, MSCs, iPSCs, TILs, and exosomes. Its offerings span process and analytical development, GMP drug product manufacture, aseptic fill and finish, QC lot release and stability studies, and regulatory consulting, supported by the MadeFast™ single-step CAR-T platform, an AI-driven robotic manufacturing partnership with Streamline Bio, and an integrated iPSC platform with Pluristyx.

Product overview

Made Scientific is a cell therapy Contract Development and Manufacturing Organization (CDMO) offering an integrated platform of manufacturing and development services. The core offering includes GMP cell therapy manufacturing, process & analytical development, aseptic fill & finish, quality control testing, and regulatory consulting. The portfolio is enhanced by the AI-driven Robotic Manufacturing Platform (via Streamline Bio partnership) for autonomous workflows, the iPSC Manufacturing Platform (via Pluristyx partnership) for GMP-ready induced pluripotent stem cell lines and derivatives, and the MadeFast™ CAR-T Manufacturing Platform with RapidCell™ for single-step rapid cell therapy production. The Made Scientific Foundry workforce development program (Core, Boost, Scholar tracks) supports training across these platforms. The company operates from a 60,000 ft² facility in Princeton, NJ with 5 ISO 7/Grade B cleanrooms, currently expanding by 12,000 ft² with 9,000 ft² of new GMP cleanroom space incorporating AI-driven robotic automation.

Differentiator

Problem solved

Functional benefit

Brands

• Made Scientific Foundry: Workforce development and training program offering in-person lab immersion, live-virtual courses, GMP-aligned training on actual CDMO equipment and workflows, academic collaborations and custom program development.

Products and services

• GMP Cell Therapy Manufacturing End-to-end GMP manufacturing services for cell therapies spanning clinical-to-commercial stages using Princeton facility infrastructure including ISO 7 / Grade B cleanrooms and BSL-2 compliance, serving biotech and pharmaceutical developers.
• Process & Analytical Development Process development and analytical method development services that identify cell therapy product quality attributes and critical process parameters early, supporting tech transfer into GMP manufacturing for cell therapy developers.
• GMP Aseptic Fill & Finish Aseptic fill and finish services for cell therapy drug products ensuring GMP-compliant final drug product manufacturing under FDA and EMA standards.
• Quality Control Testing & Stability Studies QC lot release and stability testing services for cell therapy products operated via in-house laboratory capabilities at the Princeton facility.
• Regulatory Consulting Regulatory consulting services supporting IND and BLA submissions for cell therapy developers, covering FDA and EMA regulatory pathways including Annex 1 compliance.
• Workforce Development & Training (Made Scientific Foundry) GMP-aligned workforce training program offering in-person lab immersion, live-virtual courses, and academic collaborations across three tracks — Core (in-person), Boost (virtual), and Scholar (academic partnerships) — for cell therapy professionals.
• AI-Driven Robotic Manufacturing Platform AI-driven robotic automation platform for cell therapy manufacturing enabling autonomous workflows in GMP environments, targeting rapid CAR-T production through end-to-end automation of critical process steps to reduce cycle times and cost of goods.
• iPSC Manufacturing Platform Integrated iPSC development and manufacturing platform leveraging Pluristyx's GMP-ready iPSC lines and derivative cell types including iNK and iMSC, providing cell therapy developers a single-source path from cell line to commercial supply compliant with FDA and EMA standards.
• MadeFast™ CAR-T Manufacturing Platform MadeFast™ single-step CAR-T manufacturing platform utilizing RapidCell™ technology for accelerated production of engineered cell therapies, enabling rapid autonomous cell therapy manufacturing.

Quantifiable outcome

• Enables developers to begin GMP manufacturing on day one with pre-qualified starting materials meeting 21 CFR 1271 and 21 CFR 210/211 compliance
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability1 record

Feature3 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• PluristyxcoreStrategic or Co-development Partner · 4 June 2026Strategic partnership integrating Pluristyx's GMP iPSC platform into Made Scientific's end-to-end CDMO services. Pluristyx serves as Made Scientific's iPSC supply and development partner, providing GMP-ready iPSC lines and derivative cell types (iNK, iMSC) for FDA, EMA, and global regulatory compliance. The partnership aims to compress IND timelines and reduce program costs by enabling developers to begin GMP manufacturing day one.
• RegenicinminorStrategic or Co-development Partner · 22 April 2026Manufacturing partnership to advance NovaDerm, an autologous cultured skin substitute for severe burns and chronic wounds, toward FDA Orphan product approval. Made Scientific provides end-to-end manufacturing services at its Princeton GMP facility including technology transfer, GMP clinical production, and regulatory support.
• Hemogenyx PharmaceuticalsminorStrategic or Co-development Partner · 31 March 2026Technology transfer and manufacturing partnership for HG-CT-1 CAR-T cell therapy targeting relapsed/refractory acute myeloid leukemia. Successfully completed tech transfer with FDA comparability data package confirming product equivalence between internally and externally manufactured batches.
• New Jersey Institute of Technology (NJIT)minorStrategic or Co-development Partner · 26 March 2026Partnership to co-develop graduate-level bioprocessing elective courses within NJIT's Master of Science program in Chemical and Materials Engineering. Leverages Made Scientific Foundry scholar program to deliver industry-aligned curriculum launching Spring 2027. Aims to prepare next generation of cell and gene therapy professionals.
• Streamline BiocoreTechnology or Integration · 10 February 2026Exclusive Early Adopter and Design Partner Program for AI-driven robotic manufacturing platform. Made Scientific serves as Streamline Bio's exclusive CDMO partner for the technology. Collaboration focuses on co-developing and validating autonomous CAR-T manufacturing through end-to-end automation of critical process steps, aiming to optimize cycle times and reduce cost of goods.
• Cytora TherapeuticscoreStrategic or Co-development Partner · 7 January 2026Three-way strategic partnership with Cytora Therapeutics and Zeo ScientifiX for manufacturing and commercialization of Cytora's allogeneic human oral mucosal stem cell therapy. Made Scientific serves as exclusive U.S. GMP manufacturing partner from its Princeton facility while Zeo handles U.S. commercialization. Initial focus on diabetic foot ulcers with plans for FDA Phase 2b clinical trials.
• Zeo ScientifiXcoreChannel Partner/ Reseller/ Distributor · 7 January 2026Exclusive U.S. commercialization partner in three-way partnership with Cytora Therapeutics and Made Scientific for stem cell therapy distribution. Handles market access and commercialization, initially leveraging Florida's Senate Bill 1768 stem cell access law.
• Cellergy TherapeuticsminorStrategic or Co-development Partner · 18 December 2025Partnership to advance Cellergy's mitochondrial therapy candidate CLG-001 toward first-in-human clinical studies. Made Scientific provides GMP manufacturing capabilities for trials under Israel's Ministry of Health compassionate-use framework and U.S. FDA Phase I study.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/madescientific

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Made Scientific